eyelid disease |
Disease ID | 1310 |
---|---|
Disease | eyelid disease |
Integrated Phenotype | (Waiting for update.) |
Text Mined Phenotype | HPO | Name | Sentences' Count(Total Phenotypes:1) |
Disease ID | 1310 |
---|---|
Disease | eyelid disease |
Manually Symptom | (Waiting for update.) |
Text Mined Symptom | (Waiting for update.) |
Manually Genotype(Total Text Mining Genotypes:0) |
---|
(Waiting for update.) |
All Snps(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Annotation(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Snp Trait(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
Mapped by lexical matching(Total Items:0) |
---|
(Waiting for update.) |
Mapped by homologous gene(Total Items:0) |
---|
(Waiting for update.) |
Chemical(Total Drugs:8) | |||||||||
---|---|---|---|---|---|---|---|---|---|
CUI | ChemicalName | ChemicalID | CasRN | DiseaseName | DiseaseID | DirectEvidence | PubMedIDs | ||
C0015423 | aspartame | D001218 | 22839-47-0 | eyelid diseases | MESH:D005141 | marker/mechanism | 14996049 | ||
C0015423 | azithromycin | D017963 | 83905-01-5 | eyelid diseases | MESH:D005141 | marker/mechanism | 19108788 | ||
C0015423 | fluorouracil | D005472 | 51-21-8 | eyelid diseases | MESH:D005141 | marker/mechanism | 12918558 | ||
C0015423 | moxifloxacin | C104727 | - | eyelid diseases | MESH:D005141 | marker/mechanism | 19108788 | ||
C0015423 | reserpine | D012110 | 50-55-5 | eyelid diseases | MESH:D005141 | marker/mechanism | 12237745 | ||
C0015423 | tetrabenazine | D013747 | 58-46-8 | eyelid diseases | MESH:D005141 | marker/mechanism | 3417209 | ||
C0015423 | valproic acid | D014635 | 99-66-1 | eyelid diseases | MESH:D005141 | marker/mechanism | 11018306 | ||
C0015423 | vitamin e | D014810 | 1406-18-4 | eyelid diseases | MESH:D005141 | therapeutic | 11018306 |
FDA approved drug and dosage information(Total Drugs:0) | |
---|---|
(Waiting for update.) |
FDA labeling changes(Total Drugs:0) | |
---|---|
(Waiting for update.) |